Total Funding
20
49
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
125294
Inflammatory Response Research focuses on pharmaceutical products for the treatment of inflammatory disorders.
- Loriel May: Co-Founder and CFO
About the Company
Inflammatory Response Research is a drug development company focused on pharmaceutical products for the treatment of inflammatory disorders and conditions. Their initial product is an oral combination of levocetirizine (Xyzal) and montelukast (Singulair) at specific dosing for the treatment of influenza. Parallel research is focused on an
intravenous (IV) preparation for the treatment of traumatic brain injury and severe cases of influenza.
IRR was founded in 2011 and is headquartered in Santa Barbara, California.
Women Founded
